Category: New products

  • Water Purification Technology Launched Based on Rare Earths

    Molycorp Minerals Inc., a producer of rare earths in Greenwood Village, Colorado, says it has launched of a new rare earth-based water purification technology called Xsorbx. Rare earths are a collection of mineral elements, such as cerium and lanthanum, used in advanced and strategic manufacturing products — e.g. electric car batteries, flat-screen TVs, and wind…

  • Clinical Trial Shows Results for Rheumatoid Arthritis Drug

    A six-month clinical trial of the drug fostamatinib, developed by Rigel Pharmaceuticals of South San Francisco, California, shows improved outcomes for patients with rheumatoid arthritis (RA) who responded inadequately to ongoing treatment with another RA drug, methotrexate. Fostamatinib is an inhibitor of spleen tyrosine kinase, a modulator of immune signaling. The double-blind, placebo-controlled phase 2…

  • Spanish-French Team Tops Wine Bottles with New Composite

    The Spanish research institute Tecnalia, in Bizkaia (Vizcaya), has developed a new material to replace plastic and cork as stoppers for wine bottles. The project developing this new composite, called PLACOTOP, includes the companies Plásticos Urteta in Spain and Rescoll-Societé de Recherche in France, and is funded in part by the European Commission. Plastic stoppers…

  • Clinical Study Data Published on Cortical Bone Substitute

    Orthovita Inc., a developer of medical implants in Malvern, Pennsylvania, reports today that the journal Spine published data from studies of its product Cortoss, an injectable polymer composite that mimics cortical bone. The paper reports on two pilot studies of Cortoss to treat vertebral compression fractures or VCF (paid subscription required}. The paper says Cortoss…

  • Random Number Generation for Computer Security Advances

    Computer researchers at Queen’s University Belfast in the U.K. developed a simpler and smaller way of generating random numbers, an essential property of cyber-security. Jiang Wu and Máire O’Neill of the university’s Institute of Electronics, Communications and Information Technology have produced a series of circuits for generating random numbers that are up to 50 percent…

  • GPS-Linked Training Shirt Gives Data for Runners

    A Spanish company has developed a training shirt fitted with sensors, Bluetooth transmitter, and GPS receiver to provide runners with real-time data on their performance and route, either in training or competition. The company, emxys, is a startup enterprise in Alicante, Spain, but also taking part in the European Space Agency’s (ESA’s) Business Incubation Centre…

  • Water Blade Technology Developed to Disable IEDs

    A device developed at Sandia National Laboratory in Albuquerque, New Mexico shoots a blade of water capable of penetrating steel that helps American troops in Afghanistan disable deadly improvised explosive devices, or IEDs. Sandia licensed the technology to TEAM Technologies Inc., also in Albuquerque. The company made its first shipment of some 3,000 new water…

  • Blood Disorder Gene Therapy Results Published

    The current online issue of the journal Nature features an article with the first results of a clinical trial testing gene therapy on beta-thalassemia, an inherited blood disorder. The trial tests the drug LentiGlobin, developed by bluebird bio (formerly Genetix Pharmaceuticals Inc.) of Cambridge, Massachusetts. The Nature paper describes the experiences of the first patient…

  • Robotic Catheter to Treat Cardiac Condition in Development

    Researchers from North Carolina State University (NC State) in Raleigh are developing a computerized catheter designed to make the surgical treatment of atrial fibrillation faster, cheaper, and more effective.  The device can also decrease a patient’s radiation exposure related to the treatment. Atrial fibrillation occurs when random electrical activity occurs in the upper chambers of…

  • Clinical Trial Completed for Psoriasis Antibody

    Biotie Therapies, a drug discovery and development company in Finland, completed a phase 1 clinical trial of its vascular adhesion protein 1 (VAP-1) monoclonal antibody BTT-1023 in patients with plaque psoriasis, the most prevalent type of this disease. Plaque psoriasis affects some 8 in 10 psoriasis sufferers. The clinical trial tested the safety, tolerability, and…